Skip to content

Multimodal Brain Monitoring as a Prognostic Tool for Intracerebral Hemorrhage

Multimodal Brain Monitoring as a Prognostic Tool for Intracerebral Hemorrhage - A Prospective Observational Cohort Study.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05771662
Enrollment
25
Registered
2023-03-16
Start date
2021-04-01
Completion date
2023-09-30
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage

Brief summary

To verify if there is an association between advanced multimodal brain monitoring parameters in the first 48h and fist 7 days of admission with intrahospital and six-months functional outcome, even when controlled to other factors that may influence the outcome. Secondary Goals: To describe multimodal neuromonitoring parameters variation in the first seven days of ICH and identify any trends.

Interventions

None listed

Sponsors

Universidade do Porto
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Spontaneous Intracerebral Hemorrhage * ICU admission in the first 24hours * Need for intraparenchymal Neuromonitoring * Over 18 years old

Exclusion criteria

* Tumour, Trauma or known Vascular Lesion * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Relation between multimodal brain monitoring parameters and outcome.6 monthsAssociation between advanced multimodal brain monitoring parameters of the first 48h of admission and six months functional outcome (Glasgow Outcome Score Extended)

Secondary

MeasureTime frameDescription
ICH Neuromonitoring Pattern.7 daysDescribe multimodal neuromonitoring parameters variation in the first seven days of ICH and identify trends.
ICH Neuromonitoring and Short Term Outcome28 daysAssociation between advanced multimodal brain monitoring parameters and 28 days functional outcome (Glasgow Outcome Score Extended)

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026